February, 2011The University of Texas at San Antonio (UTSA) today announced that C. Mauli Agrawal, David and Jennifer Spencer Distinguished Chair for the Dean of Engineering and Peter Flawn Professor in Biomedical Engineering, has been re-appointed to serve a second two-year term on the advisory board of the Texas Emerging Technology Fund (ETF). Agrawal’s new term will expire August 31, 2012.
“At the recommendation of Governor Rick Perry, the Texas Emerging Technology Fund was established in 2005 by the Texas Legislature to strengthen the state’s economy by providing $200 million in funding to support promising technology start-up companies in Texas and promote innovation by recruiting outstanding scientists to Texas’ universities,” said Agrawal. “This is a very exciting time for Texas, and I am honored to serve on the fund’s advisory board for a second term.”
A mechanical engineer and materials scientist by training, Agrawal is recognized internationally as a scholar in orthopedic and cardiovascular biomaterials. His career spans about two decades, during which his research has generated nearly 300 scientific publications and conference papers. Additionally, he has edited or co-edited four scientific books, served on the editorial boards of several leading scientific journals and delivered more than 75 scientific lectures on four continents. In 2008, Agrawal was inducted a Fellow of the International Union of Societies for Biomaterials. He is also a Fellow of the American Institute for Medical and Biological Engineering, an honor reserved for those representing the top two percent of their field. In 2010, he was honored by BioMed SA with the Julio Palmaz Award for Innovation in Health Care and the Biosciences. The award is given to the one individual each year that makes the most significant contributions to advance biomedicine.
In addition to his scholarly accomplishments, Agrawal is an entrepreneur who has been issued and has pending 18 U.S. patents for technology he created or contributed to during the course of his research. Some of those patents have been licensed commercially, resulting in the formation of three biomedical start-ups in San Antonio including Xilas Medical Inc. (now Diabetica Solutions) which offers products to resolve diabetic foot problems and was the first company in Texas to be funded by the ETF. More recently, Agrawal and his colleagues co-founded GenOsteo, a company that will soon commercialize products to regenerate large defects in bone. The intellectual property supporting GenOsteo garnered UTSA its first commercial license.
Agrawal’s professional affiliations include the Society for Biomaterials, Orthopaedic Research Society, Tissue Engineering Society, American Academy of Orthopedic Surgeons and the Biomedical Engineering Society.
Agrawal earned his doctorate in Materials Science from Duke University and his master’s and bachelor’s degrees in mechanical engineering from Clemson University and the Indian Institute of Technology, respectively.
The University of Texas at San Antonio is one of the fastest growing higher education institutions in Texas and one of nine academic universities and six health institutions in the UT System. As a multicultural institution, UTSA aims to be a national research university providing access to educational excellence and preparing citizen leaders for the global environment.
UTSA serves more than 30,300 students in 65 bachelor’s, 49 master’s and 21 doctoral degree programs in the colleges of Architecture, Business, Education and Human Development, Engineering, Honors, Liberal and Fine Arts, Public Policy, Sciences and Graduate School. Founded in 1969, UTSA is an intellectual and creative resource center and a socioeconomic development catalyst for Texas and beyond. More information online at www.utsa.edu/today.